CECR and BL-NCE funding extensions announced

Guest Contributor
February 5, 2013

The Networks of Centres of Excellence (NCE) secretariat has released the results of its competition to determine which of the original recipients of its two industry-facing programs will receive extended funding. The competition awarded renewed funding for four of the original 11 Centres of Excellence for Commercialization and Research (CECR) and one of the four Business-Led NCEs (BL-NCE). The successful CECRs are the Centre for Drug Research and Development (CDRD) ($8 million); Centre for Probe Development and Commercialization (CPDC) ($13.8 million); MaRS Innovation ($14.95 million); and, Prostate Centre's Translational Research Initiative for Accelerated Discovery and Development (PC-TRIADD) ($11.33 million). The successful BL-NCE was the Quebec Consortium for Drug Discovery (CQDM), which will receive $11.7 million over five years. A full report will be in the next issue of RE$EARCH MONEY...

Other News

Events For Leaders in
Science, Tech, Innovation, and Policy

Discuss and learn from those in the know at our virtual and in-person events.

See Upcoming Events

You have 1 free article remaining.
Don't miss out - start your free trial today.

Start your FREE trial    Already a member? Log in


By using this website, you agree to our use of cookies. We use cookies to provide you with a great experience and to help our website run effectively in accordance with our Privacy Policy and Terms of Service.